Home/ Supplements/ Niacin/ Redline Xtreme Watermelon

Redline Xtreme Watermelon

product on market Liquid VPX Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The profile contains B vitamins, including Niacin, B6, Folate, and B12, which are essential for energy metabolism and cellular function. There is strong evidence supporting the role of these nutrients in supporting metabolic processes. However, the overall evidence coverage for this specific formulation is very limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Redline Xtreme Watermelon
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Bottle(s)
Serving Size
1
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
5 mg (25% DV)
Within RDA (0.4× RDA) 196 studies (A:5, B:63)
800 mcg (40% DV)
Within RDA (0.6× RDA) 114 studies (A:3, B:35)
24 mcg (6% DV)
Within RDA (0.1× RDA) 226 studies (A:10, B:105)
3 mcg (50% DV)
1.3× RDA — within safe limits 139 studies (A:1, B:44)
Electrolyte Matrix

Other Ingredients

highly purified water Citric Acid Anhydrous Natural and Artificial flavors Sucralean brand Sucralose Malic Acid Sodium Benzoate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Warnings & Precautions

READ ENTIRE LABEL BEFORE CONSUMING

Additional Information

ARTIFICIALLY FLAVORED

XTREMELY New

XTREME SHOT

{chart} DRINK REGULATION GAUGE

Not a significant source of vitamin A, vitamin C, calcium and iron.

V001

Metadata

Product Details

UPC / SKU10764 00303 4
DSLD Entry Date2014-05-23
Product TypeOther Combinations
FormLiquid
BrandVPX
DSLD ID33430
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.